RUNX2 and hyperlipidemia: Previous studies have reported that statins may improve hyperlipidemia and enhances femoral head neovascularization through suppresses PPARγ expression and activates Wnt3a/LRP5/b-catenin/RUNX2 signaling pathway in steroid-induced animal models [31–33].